GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Notes Receivable

3SBio, (FRA:YFK) Notes Receivable : €0.0 Mil (As of Dec. 2016)


View and export this data going back to . Start your Free Trial

What is 3SBio, Notes Receivable?

3SBio,'s Notes Receivable for the quarter that ended in Dec. 2016 was €0.0 Mil.

3SBio,'s annual Notes Receivable declined from Dec. 2014 (€16.42 Mil) to Dec. 2015 (€0.00 Mil) but then stayed the same from Dec. 2015 (€0.00 Mil) to Dec. 2016 (€0.00 Mil).


3SBio, Notes Receivable Historical Data

The historical data trend for 3SBio,'s Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Notes Receivable Chart

3SBio, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec14 Dec15 Dec16
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.66 7.22 16.42 - -

3SBio, Semi-Annual Data
Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.42 10.95 - - -

3SBio, Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


3SBio, Notes Receivable Related Terms

Thank you for viewing the detailed overview of 3SBio,'s Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio, (FRA:YFK) Business Description

Traded in Other Exchanges
N/A
Address
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines